TSS
IRWD icon

Two Sigma Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

Two Sigma Securities’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-41,734
Closed -$439K – 3071
2023
Q1 		$439K Buy
41,734
+27,560
+194% +$309K 0.01% 1358
2022
Q4 		$176K Buy
+14,174
New +$161K 0.01% 1980
2017
Q3 		– Sell
-14,344
Closed -$227K – 1064
2017
Q2 		$227K Buy
+14,344
New +$208K 0.04% 489

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Two Sigma Securities's IRWD Position: Q2 2023 in Review

Two Sigma Securities sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 41,734 shares — an estimated $439K sold.

Two Sigma Securities first reported a position in IRWD in Q2 2017 and held it in 3 quarters. The position peaked at $439K in Q1 2023. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

  • Two Sigma Securities reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 41,734 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $439K.
  • Two Sigma Securities first reported a position in Ironwood Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • Two Sigma Securities's Ironwood Pharmaceuticals position peaked at $439K in Q1 2023.
  • 252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.